Key Ingredients
Empagliflozin 25 mg: An SGLT2 inhibitor that lowers blood sugar by promoting glucose excretion through urine, while also supporting weight management and cardiovascular health.
Linagliptin 5 mg: A DPP-4 inhibitor that increases incretin hormone levels, enhances insulin secretion, reduces glucagon release, and helps control blood sugar—especially after meals.
Benefits
Dual Mechanism for Optimal Glycemic Control: Combines SGLT2 inhibition with DPP-4 inhibition for effective, stable sugar management.
Reduced Post-Meal Glucose Surges: Linagliptin slows glucose absorption and improves hormonal regulation.
Supports Weight & Metabolic Benefits: Empagliflozin may promote mild weight reduction and improved metabolic markers.
Lower Risk of Hypoglycemia: Both agents work in a glucose-dependent manner, reducing the likelihood of low blood sugar.
Convenient Once-Daily Dosing: Improves treatment compliance and long-term diabetes control.
Usage Instructions
Take orally once daily or as directed by a healthcare professional. Maintain a healthy diet and regular physical activity for better results.
Side Effects
May include increased urination, sore throat, headache, nasal congestion, or urinary/genital infections. Seek medical advice if severe reactions occur.
General Information
- Form: Tablet
- Composition: Empagliflozin 25 mg + Linagliptin 5 mg
- Strength: 5 mg (Dosage strength category)
- Brand: EMPAGIL-L
- Packaging Size: 10×10
- Packaging Type: Alu-Alu
- Usage: Type 2 Diabetes Management
- Country of Origin: India
Globus Labs brings you WHO-GMP–certified, high-quality Empagliflozin 25 mg + Linagliptin 5 mg sourced from reputed pharmaceutical manufacturers. EMPAGIL-L is formulated to deliver safe, potent, and clinically trusted support.
